Revenue rose 14% to RON72.3 million, while expenditure increased by 17% to RON55.8 million, according to financial results published Monday.
Thus, nine-month profit rose 9% on the year, to RON13.7 million, from RON12.6 million.
At the end of September, the company had debts cumulating RON20.9 million, while receivables cumulated RON24.9 million.
Biofarm has a share capital of RON109.4 million, divided int0 1.09 billion shares with a face value of RON0.1.
Company shareholders include SIF Oltenia (SIF5.RO) with 25.29%, SIF Banat-Crisana (SIF1.RO) with 16.67%, SIF Moldova (SIF2.RO) with 12.21% and privatization watchdog AVAS with 1.04%.
Biofarm shares closed up 1% Monday, to RON0.205. (EUR1=RON4.3448)